SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ajanta Pharma
Ajanta Pharma
BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01049|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 02, 16:01
1516.30
-3.05 (-0.2%)
VOLUME 16,872
LIVE
NSE
Sep 02, 16:01
1515.50
-7.9 (-0.52%)
VOLUME 130,449
News on Ajanta Pharma
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Super Six short term picks for September 2 

8.58 am | 02 Sep 2015 |  Source: CNBC-TV18

Gaurav Bissa of LKP Securities is of the view that one may sell Bank of Baroda with a target of Rs 164....

Bull's Eye: Sell Bharat Forge, JSW Steel, buy Voltas 

7.59 am | 01 Sep 2015 |  Source: CNBC-TV18

Jay Thakkar of Sharekhan advises buying Dr Reddy's Laboratories with a target of Rs 4390....

Ajanta Pharma consolidated Jun '15 sales at Rs 391.35 crore

10.20 am | 14 Aug 2015 |  Source: Moneycontrol.com

Ajanta Pharma has reported a consolidated total income from operations of Rs 391.35 crore and a net profit of Rs 83.84 crore for the quarter ended Jun...

Buy Bosch, Ajanta Pharma: Manas Jaiswal 

3.28 pm | 11 Aug 2015 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com recommends buying Bosch and Ajanta Pharma....

Bull's Eye: Buy Gruh Fin, JSPL, Voltas, Pidilite, DCB Bank 

7.57 am | 05 Aug 2015 |  Source: CNBC-TV18

According to Dharmesh Kant of India Nivesh Securities, one may buy Gateway Distriparks with a target of Rs 390....

Ajanta Pharma gets approvals for 3 ANDAs

10.40 am | 04 Aug 2015 |  Source: Moneycontrol.com

Ajanta Pharma has received final approval for its 3 ANDAs by USFDA....

1
Quick Links for Ajanta Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.